William Blair Issues Positive Outlook for DLB Earnings

Dolby Laboratories, Inc. (NYSE:DLB) – Equities research analysts at William Blair upped their Q3 2025 earnings per share (EPS) estimates for Dolby Laboratories in a report released on Wednesday, November 20th. William Blair analyst R. Schackart now forecasts that the electronics maker will post earnings of $0.52 per share for the quarter, up from their prior forecast of $0.43. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.67 per share.

Other equities research analysts also recently issued research reports about the company. Rosenblatt Securities raised their price target on Dolby Laboratories from $98.00 to $100.00 and gave the company a “buy” rating in a report on Wednesday, November 20th. Barrington Research restated an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Wednesday, November 20th. Finally, StockNews.com lowered shares of Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a research note on Tuesday.

Dolby Laboratories Trading Up 0.0 %

Shares of NYSE DLB opened at $80.33 on Monday. The company has a market capitalization of $7.66 billion, a P/E ratio of 29.64 and a beta of 0.98. Dolby Laboratories has a 12 month low of $66.35 and a 12 month high of $90.06. The stock has a 50 day moving average of $74.50 and a 200-day moving average of $75.96.

Dolby Laboratories announced that its board has authorized a share repurchase plan on Wednesday, August 7th that permits the company to buyback $350.00 million in shares. This buyback authorization permits the electronics maker to reacquire up to 5% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s board believes its stock is undervalued.

Dolby Laboratories Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 10th. Stockholders of record on Tuesday, December 3rd will be issued a dividend of $0.33 per share. The ex-dividend date is Tuesday, December 3rd. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.64%. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.30. Dolby Laboratories’s dividend payout ratio (DPR) is currently 48.71%.

Insider Activity

In other news, CEO Kevin J. Yeaman sold 28,512 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total value of $2,113,309.44. Following the completion of the sale, the chief executive officer now directly owns 83,721 shares in the company, valued at approximately $6,205,400.52. The trade was a 25.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Peter C. Gotcher sold 6,079 shares of the stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $78.96, for a total value of $479,997.84. Following the sale, the director now directly owns 37,593 shares in the company, valued at $2,968,343.28. This represents a 13.92 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 91,591 shares of company stock valued at $7,158,807. 39.54% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Boston Trust Walden Corp increased its holdings in Dolby Laboratories by 3.1% in the 2nd quarter. Boston Trust Walden Corp now owns 376,793 shares of the electronics maker’s stock valued at $29,853,000 after buying an additional 11,177 shares during the period. Panagora Asset Management Inc. bought a new position in Dolby Laboratories in the 2nd quarter valued at approximately $3,348,000. Pacer Advisors Inc. boosted its holdings in shares of Dolby Laboratories by 47.5% during the 2nd quarter. Pacer Advisors Inc. now owns 23,320 shares of the electronics maker’s stock valued at $1,848,000 after acquiring an additional 7,509 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of Dolby Laboratories during the second quarter worth about $1,157,000. Finally, Van ECK Associates Corp grew its holdings in Dolby Laboratories by 40.0% during the 3rd quarter. Van ECK Associates Corp now owns 34,881 shares of the electronics maker’s stock worth $2,535,000 after acquiring an additional 9,967 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.